Skip to content

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

– FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study –

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
See Full Bio
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Similar Posts

Infographic on the 40°C chain reaction in the body, left side shows Phase 1 with cardiovascular strain, right side shows Phase 2 with coagulation and organ failure

40 Degrees: Deadly heatwave hits Germany

40 degrees: Heatwave in Germany can trigger deadly chain reaction in the body. Credits: LabNews Media LLC

Algae flour improves gluten-free cookies

Campinas (LabNews Media LLC) – Flour from the brown alga Sargassum filipendula can significantly increase the nutrient density and digestibility of gluten-free cookies. Even an addition of just… 

more »Algae flour improves gluten-free cookies

Sex-specific immune pathway discovered in glioblastoma

Miami (LabNews Media LLC) – A previously unknown, sex-specific immune mechanism could improve the treatment of the aggressive brain tumor glioblastoma in women in the future. Researchers from Sylvester Comprehensive…

more »Sex-specific immune pathway discovered in glioblastoma